We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Study on Cerebral Malaria Could Lead to Diagnostic Test

By Biotechdaily staff writers
Posted on 16 May 2007
The results of a study on children in Gabonese hospitals show that, in 90% of children suffering from cerebral malaria, antibodies specifically recognize a protein in the brain--cerebral alpha-spectrin.

The study provides a lead on how to perfect a diagnostic test, which should allow for better patient care. More...
Scientists at Centre National de la Recherche Scientifique (CNRS; Paris France) and the Pasteur Institute (Paris, France) collaborating with physicians in Gabon, have just undertaken a study on cerebral malaria in children living in an endemic region. This study, which was published in the April 2007 issue of the journal PLoS ONE, should allow clinicians to better understand this severe form of malaria which affects 20-40% of people infected by the Plasmodium falciparum parasite, and is fatal in 30–50% of cases.

A particular immunologic phenomenon has been observed in people infected by P falciparum. The B-lymphocytes, the main antibody-producing cells, increase their secretion of a range of antibodies, notably those directed against various components of the organism (such as DNA and red blood cells). Today, it is still not known if these autoantibodies are the result of pathologic mechanisms associated with the infection or if they contribute to the events leading to severe forms of the illness.

The French and Gabonese teams sought to understand if some of these autoantibodies were directed against the molecules in the brain. They worked on the blood samples of some 350 children aged between 6 months and five years who had been treated in Gabonese hospitals. The cohort was divided into five groups: control patients (without parasites in the blood), asymptomatic patients, patients developing simple malaria, patients suffering from serious, non-cerebral malaria (notably severe anaemia), and finally patients suffering from neurologic infection. The results of the study showed that in 90% of children suffering from cerebral malaria, the antibodies specifically recognized a protein in the brain, cerebral alpha-spectrin.

This study also opened a new sector of malaria research; understanding the role of autoantibodies directed against cerebral antigens in the development of the illness.


Related Links:
Centre National de la Recherche Scientifique
Pasteur Institute

Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image

Rapid Testing Panel Simultaneously Detects 15 Drugs of Abuse in Urine Within 21 Minutes

Illicit drug use and excessive use of prescription medicine is growing across the US amid a severe opioid crisis. Although overdose fatalities were reported to have declined by nearly 27% in 2024, many... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.